Navigation Links
Piedmont Heart Institute Welcomes Cardiology of Georgia
Date:4/1/2008

than 30 years. It is only natural that we pursue this affiliation under the Piedmont Heart Institute with its vision of advancing cardiovascular care for those we serve."

Since the mid-1960's, Piedmont Hospital has continued to earn recognition as a leader in the prevention and treatment of heart disease. Piedmont was one of Georgia's first hospitals to establish a dedicated coronary care unit (CCU), the first to hire a full-time director of a community CCU, and one of the first in the country to use telemetry monitors throughout the hospital. Piedmont has successfully developed cardiac catheterization, interventional cardiology, comprehensive electrophysiology and arrhythmia services, advanced heart failure management, open-heart surgery, and peripheral vascular services. This expertise culminated in 1994 with the centralization of services at the Fuqua Heart Center of Atlanta at Piedmont Hospital.

About Cardiology of Georgia

Cardiology of Georgia (COG) is a member of Piedmont Heart Institute Physicians. With 20 physicians practicing in eight locations across greater Atlanta, COG's cardiac specialists have cared for Georgians for over 30 years, providing a full range of cardiovascular patient care in office, outpatient and inpatient settings.

About the Piedmont Heart Institute

The Piedmont Heart Institute (PHI) is the first integrated cardiovascular healthcare delivery program affiliated with a community health system in greater Atlanta and is headquartered on the campus of Piedmont Hospital, a 481-bed tertiary care facility offering all major medical, surgical and diagnostic services. Offering a continuum of patient care, including primary and secondary prevention, outpatient and inpatient cardiovascular care, and appropriate quality measures and metrics to demonstrate enhanced outcomes, PHI combines renowned cardiologists and the 162-bed Fuqua Heart Center of Atlanta to propel new programs in cardiovascular research, education
'/>"/>

SOURCE Piedmont Heart Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Kent Riddle Named To Piedmont Triad Biotechnology Development Group
2. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
3. ATS Medical Expands Open Pivot Heart Valve Offerings
4. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
7. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
8. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
9. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
10. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... July 18, 2014 from the NYSE MKT LLC ... plan to regain compliance with continued listing standards ... is continuing the Company,s listing and has granted ...
(Date:7/24/2014)... , July 24, 2014  Neogen Corporation (Nasdaq: ... future forecasts of its potential revenue from new rodenticide ... to investors and analysts on July 22, 2014, Neogen,s ... analysts regarding this research. "It was my ... about the potential of a new type of rodenticide, ...
(Date:7/24/2014)... Canada (PRWEB) July 24, 2014 The ... Optimizing Dose Escalation in First in Human Studies” will ... make better go/no-go decisions. , With increasing R&D costs ... pharmaceutical companies need to maximize the knowledge collected in ... decisions and improve success in late stage development. , ...
(Date:7/24/2014)...   Cypher Genomics, Inc., the genome ... Adam Simpson as president and chief operating ... annotation and interpretation of individual human genomes for ... technology has the potential to play a transformative ... optimizing therapeutic approaches and reducing adverse drug reactions," ...
Breaking Biology Technology:CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3
... BUFFALO, N.Y., April 19, 2011 Today, H. ... CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused ... Kinase (FAK) inhibitors for cancer, provided a company ... leaders at the Celebration of Innovation Showcase 2011 ...
... April 19, 2011 Practice Fusion, the leading EHR ... the addition of Paul Willard as Vice President of ... Development. The news of the expanded executive team follows ... the Electronic Health Record system , led by ...
... Tissue Genesis, Inc., an emerging leader in adult ... has begun clinical trials for peripheral vascular disease (PVD) ... at the University of Louisville Hospital.  Tissue Genesis is ... patient,s own adipose-derived adult stem cells (ASCs) prepared at ...
Cached Biology Technology:CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 2CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 3CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 4Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director 2Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director 3Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director 4Tissue Genesis Begins FDA-Approved Clinical Trial 2Tissue Genesis Begins FDA-Approved Clinical Trial 3
(Date:7/25/2014)... PITTSBURGH -- The routine use of a molecular ... likelihood of performing the correct initial surgery for ... from the University of Pittsburgh Cancer Institute (UPCI), ... the UPMC/UPCI Multidisciplinary Thyroid Center and other diagnostic ... the correct initial surgery by 30 percent, according ...
(Date:7/24/2014)... New York, NY - July 24, 2014 -- Keryx ... results from the long-term, randomized, active control Phase 3 ... ferric iron-based phosphate binder, for the treatment of hyperphosphatemia ... The PERFECTED study (PhosphatE binding and iRon delivery with ... the Journal of the American Society of Nephrology ...
(Date:7/24/2014)... Acoustic disturbance has different effects on different species ... the Universities of Bristol and Exeter which tested ... sooner to a flying seagull predator model when ... observed in European minnows. , Lead author ... Sciences said: "Noise levels in many aquatic environments ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... , A group of Japanese researchers, who publish their findings ... Biomimetics , have succeeded in building a fully functional replica ... they have filmed their model butterfly flying. Among the ... wing area is very large relative to their body mass. ...
... to minimize the use of chemical herbicides need creative solutions ... research at the University of Illinois on Canada thistle, Sudangrass ... smother crop. "Sudangrass get very tall. It outcompetes the ... occur in the thistle," said U of I weed scientist ...
... NC Social status in paper wasps is established earlier ... month in the journal PLoS ONE . While ... appearance and are fixed from birth, paper wasp society is ... can climb the social ladder and become a queen. Now, ...
Cached Biology News:Sudangrass recommended to combat Canada thistle 2Sudangrass recommended to combat Canada thistle 3The making of a queen: Road to royalty begins early in paper wasps 2
... Lab Quantas unique combination of Coulter ... resolution capabilities and accurate cell counting. ... wavelengths, including UV, allowing flexible fluorochrome ... applications typically only achievable with larger, ...
... FC 500 Series is a ... the most advanced technologies available. ... flexible testing, powerful software and ... help researchers optimize their overall ...
... crosslinked to protein G-agarose beads which can ... heart mitochondria. Also included are 2 mg ... ,The pyruvate dehydrogenase complex (PDH) immunocapture kit ... of tissue. This facilitates the subsequent analysis ...
... PULSin may be superior to transfection in ... transfection, with PULSin you can study lethal ... course of proteins in cells. Likewise, delivery ... than traditional RNA interference experiments. ,With ...
Biology Products: